SHENZHEN INTL_Providing professional financial news and data related to SHENZHEN INTL, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

SHENZHEN INT'L (00152.HK): Completes Issue of RMB 1 Billion 2026 Fifth Tranche Medium-Term Notes at 1.65% Coupon

Tags：

SHENZHEN INTL 00152.HK medium-term notes

2026-09-14

Finance
ORANGE SKY G H (01132.HK): Appoints Du Yan as Independent Non-Executive Director and Chairman of the Remuneration Committee, Replacing Huang Siying
Finance
VALUES CULTURAL (01740.HK): Appoints Miao Jian as Executive Director and Co-Chief Executive Officer, with Cai Xiaoxin Serving as Co-CEO
Finance
BOAN BIOTECH (06955.HK): Masked PD-1/IL-2 Prodrug BA1203 Approved for Clinical Trial in China for Multiple Solid Tumours
Finance
WEIHAI BANK (09677.HK): Completes Issue of RMB 500 Million 2026 Green Financial Bonds (First Tranche) at 1.65% Coupon
Finance
HENGRUI PHARMA (01276.HK): Marketing Application for Class 1 Innovative Drug SHR-2004 Injection Accepted by NMPA for VTE Prevention After Knee Replacement Surgery
Finance
PUBLIC FIN HOLD (00626.HK): Appoints Somerley Capital as Independent Financial Adviser for Public Bank's Privatisation Proposal by Scheme of Arrangement
Finance
KWAN YONG (09998.HK): Positive Profit Alert, Expects FY2026 Net Profit Attributable to Owners of About SGD 19.8 Million
Finance
YIDU TECH (02158.HK): Affiliate Yidu Cloud Wins Bid for Ageing and Health Innovation Translation Project of Xiangya Hospital's National Clinical Medical Research Centre
Finance
HX COLDCHAIN (01641.HK): Subscribes for RMB 20 Million Structured Deposit with Bank of Communications, Constituting a Discloseable Transaction
Finance
CMS (00867.HK): Innovative Drug CMS-D001, a Highly Selective TYK2 Inhibitor, Receives Drug Clinical Trial Approval Notice for Systemic Lupus Erythematosus Indication

Scan QR Code

Download App